Sort
50,496 grants matching “lung cancer”
Planning and Evaluation Core
$562,676Clement K. Gwede · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2020 · CA
Radiomics of NSCLC
$562,652Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2016 · CA
Computational Approaches for RNA Structure and Function Determination
$562,649Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Western Regional Community Clinical Oncology Program
$562,644Banner Good Samaritan Medical Center · U10 · FY2004 · CA
Real time scattered x-ray imaging for tumor motion tracking in radiotherapy.
$562,587Xun Jia · Johns Hopkins University · R01 · FY2025 · CA
Methods for Etiologic Studies of Diet and Cancer
$562,570Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer
$562,559Avrum E Spira · Boston University Medical Campus · R01 · FY2011 · CA
Hexokinase 2 and cancer therapy
$562,533Nissim Hay · University Of Illinois At Chicago · R01 · FY2023 · CA
Hexokinase 2 and cancer therapy
$562,533Nissim Hay · University Of Illinois At Chicago · R01 · FY2022 · CA
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies
$562,502Vito Quaranta · Vanderbilt University · R01 · FY2017 · CA
Probing the Role of Insulin-Like Growth Factor-Binding Protein 3 and Humanin in Regulating Hyaluronan Function
$562,500Hedeel I Guy Evans · Eastern Michigan University · R15 · FY2025 · GM
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
$562,380Melissa J Suter · Massachusetts General Hospital · R01 · FY2017 · CA
Credentialing next-generation human glioma models for precision therapeutics
$562,355Christopher Ryan Miller · University Of Alabama At Birmingham · R01 · FY2025 · CA
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer
$562,338Evanthia Theodosiou Roussos Torres · University Of Southern California · R01 · FY2025 · CA
Arsenic and child respiratory health in Bangladesh
$562,335Allan H Smith · University Of California Berkeley · R01 · FY2009 · HL
Construal level as a novel pathway for affect regulation and cancer control
$562,286Elliot Todd Berkman · University Of Oregon · R01 · FY2024 · CA
UCDCCC NCTN UG1 PROGRAM
$562,222David R Gandara · University Of California At Davis · UG1 · FY2025 · CA
Biomarkers of toxic response to low nicotine cigarette smoke
$562,125Ian Alexander Blair · University Of Pennsylvania · R01 · FY2011 · CA
A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments
$562,063David Kevin Wood · University Of Minnesota · R01 · FY2023 · CA
Culturally and Linguistically Adapted Physical Activity Intervention for Latinas
$562,037Bess Hya Marcus · University Of California, San Diego · R01 · FY2011 · NR
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
$562,022Deepak Nijhawan · Ut Southwestern Medical Center · R01 · FY2020 · CA
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
$562,022Deepak Nijhawan · Ut Southwestern Medical Center · R01 · FY2021 · CA
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
$561,956Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
Project 1: Tobacco Retailer Density, Smoking and Tobacco-Related Disease
$561,930Kurt M. Ribisl · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
INTEGRIN-TARGETING TRANSFORMABLE NANOMEDICINE FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
$561,888University Of California, Davis · · FY2025 · Defense Health Agency